David McErlane, Group President of Biologics at Catalent, shares how integrated expertise in biologics helps simplify complexity, accelerate development, and deliver therapies to patients faster.
David McErlane
Advertisement
Articles by David McErlane
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Sept. 22, 2025
2
IDT Debuts Protein Solution to Improve CRISPR Knock-In Accuracy
3
100% Pharmaceutical Tariff Will Reshape US Biopharm Manufacturing Supply Chains
4
Fresenius Kabi Contract Manufacturing Focuses on Your Success
5
